Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors

Documenti analoghi

• Loss of PTPRS elicits potent metastatic capability and resistance to temozolomide in glioblastoma
  di: Yihua Zhang, et al.
  Pubblicazione: (2024)
• Climate-change and mass mortality events in overwintering monarch butterflies
  di: Narayani Barve
  Pubblicazione: (2012)
• AI-enabled security mechanisms for WLANs: ensuring robust and adaptive protection in wireless networks
  di: Sachan, Ram Chandra, et al.
  Pubblicazione: (2025)
• Primary splenic ectopic pregnancy: A case report and literature review of a rare issue
  di: Verrazzo Paolo, et al.
  Pubblicazione: (2024)
• Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes
  di: Lan Chen, et al.
  Pubblicazione: (2024)